Investigation of urinary miRNA profile changes in amphotericin B-induced nephrotoxicity in C57BL/6 mouse, Sprague–Dawley rats and Beagle dogs
Toxicological Sciences · 2025
DOI: 10.1093/toxsci/kfaf029 ↗Kurz gefasst
Fachartikel in der Zeitschrift Toxicological Sciences, 2025. Verfasst von Adeyemi O Adedeji und 3 weiteren Autor:innen. Beteiligte Einrichtung: Genentech, A Member of the Roche Group, South San Francisco, CA 94080, United States. Hauptthemen laut MEDLINE: MicroRNAs, Amphotericin B, Kidney, Kidney Diseases. Die Arbeit nennt 73 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Johnson & Johnson Innovative Medicine, Critical Path Institute's, Predictive Safety Testing Consortium.
Abstract (Originalsprache)
MicroRNA (miRNAs) have been associated with drug-induced kidney injury (DIKI). However, there are few reports on the utility of miRNAs, when monitoring for nephrotoxicity across multiple species. The purpose of this study was to assess the value of urinary miRNA profile changes as renal safety biomarkers, when monitoring for kidney injury in investigative toxicology studies. To this end, we evaluated urine miRNA expression levels in response to amphotericin B (AmpB)-induced nephrotoxicity in mice, rats, and dogs. The results showed that 35 miRNAs were significantly differentially expressed across the 3 species in response to the induced renal injuries. Dogs showed the highest number of miRNAs with significant changes. miR-205-5p and miR-31-5p were the most consistently altered miRNA biomarkers across all 3 species. In rodents, these 2 miRNAs were the most sensitive markers and showed comparable or better sensitivities than the previously published urine protein biomarkers with the same nephrotoxicant. In dogs, none of the upregulated miRNAs were as sensitive as urine clusterin protein as observed in a previously published study with AmpB. Taken together, these miRNAs could complement the more established urinary protein biomarkers in monitoring DIKI in mice, rats, and dogs. To our knowledge, this is the first report that demonstrates the comparative utility of urinary miRNAs for the early detection of DIKI across 3 nonclinical animal models.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Genentech, A Member of the Roche Group, South San Francisco, CA 94080, United States.
- Abcam, Waltham, MA 02453, United States.
- Johnson & Johnson Innovative Medicine, La Jolla, CA 92121, United States.
ORCID-Profile: Adeyemi O Adedeji
Förderung
- Johnson & Johnson Innovative Medicine
- Critical Path Institute's
- Predictive Safety Testing Consortium
- Nephrotoxicity Working Group
- Critical Path Institute
- FDA HHS
- HHS
- Critical Path Institute’s
Zitieren
APA
Adedeji, A. O., Tackett, M. R., Tejada, G., & McDuffie, J. E. (2025). Investigation of urinary miRNA profile changes in amphotericin B-induced nephrotoxicity in C57BL/6 mouse, Sprague–Dawley rats and Beagle dogs. Toxicological Sciences. https://doi.org/10.1093/toxsci/kfaf029
Vancouver
Adedeji AO, Tackett MR, Tejada G, McDuffie JE. Investigation of urinary miRNA profile changes in amphotericin B-induced nephrotoxicity in C57BL/6 mouse, Sprague–Dawley rats and Beagle dogs. Toxicological Sciences. 2025. doi:10.1093/toxsci/kfaf029
BibTeX
@article{Adedeji2025,
author = {Adedeji, Adeyemi O and Tackett, Michael R and Tejada, Genesis and McDuffie, James E},
title = {Investigation of urinary miRNA profile changes in amphotericin B-induced nephrotoxicity in C57BL/6 mouse, Sprague–Dawley rats and Beagle dogs},
journal = {Toxicological Sciences},
year = {2025},
doi = {10.1093/toxsci/kfaf029}
}
EUVIMED